Category: Johnson Johnson

EU and Vietnam to Exclude China-Made Vaccines

The European Union is expected to exclude Chinese-made vaccines from its “vaccine passport” certification program because they are not approved by the European Medicines Agency (EMA). At the same time, Vietnam is reportedly buying large quantities of COVID-19 vaccines from Western counties and Russia, but not China. On March 12, Euronews reported that the EU is…


EU and Vietnam Exclude China-Made Vaccines

The European Union is expected to exclude Chinese-made vaccines from its “vaccine passport” certification program because they are not approved by the European Medicines Agency (EMA). At the same time, Vietnam is reportedly buying large quantities of COVID-19 vaccines from Western counties and Russia, but not China. On March 12, Euronews reported that the EU is…


Canadian Bishops Issue Clarification on Notice Regarding AstraZeneca, Johnson & Johnson Vaccines

The Canadian Conference of Catholic Bishops (CCCB) clarified on March 11 regarding an earlier notice they sent to Catholics, recommending the choice of alternatives over the AstraZeneca and Johnson & Johnson COVID-19 vaccines due to their use of “abortion-derived cell lines in their development, production, and confirmatory testing.” “This Note was published in response to…


Johnson & Johnson Appeals $2 Billion Cancer Verdict Over Baby Powder to Supreme Court

Drugmaker Johnson & Johnson is asking the Supreme Court to review a $2.11 billion jury verdict from Missouri over baby powder it produced that allegedly contained asbestos that caused ovarian cancer. In addition to a vaccine used against the CCP virus, which causes the disease COVID-19, the 135-year-old New Jersey-headquartered company has been known for…


Canada Set to Receive More Than 910,000 Doses of COVID-19 Vaccines This Week

OTTAWA—Canada is set to receive 910,000 COVID-19 vaccine doses this week as pharmaceutical companies ramp up deliveries to make good on their contractual obligations by the end of the month. The Public Health Agency of Canada says the country will receive nearly 445,000 shots from Pfizer-BioNTech for the second week running as the companies settle…


FDA Authorizes Johnson & Johnson’s Single Dose COVID-19 Vaccine

The U.S. government on Saturday authorized Johnson & Johnson’s single-dose COVID-19 vaccine, enabling millions more Americans to be vaccinated in the coming weeks and setting it up for additional approvals around the world. The U.S. Food and Drug Administration announced the emergency use authorization for adults aged 18 and older following Friday’s unanimous endorsement by…


Advisory Panel Endorse J&J COVID-19 Vaccine For FDA Authorization

A panel of expert advisers to the U.S. Food and Drug Administration on Friday voted in favor of authorizing Johnson & Johnson’s one-dose COVID-19 vaccine for emergency use, bringing it an important step closer to a U.S. rollout. The FDA is likely to authorize the vaccine for emergency use within a day or so, making…


J&J Projects Having COVID-19 Vaccine Doses for 20 Million Americans by End of March

A COVID-19 vaccine being considered by drug regulators could help quickly boost the number of Americans getting shots against the CCP (Chinese Communist Party) virus. Johnson & Johnson is prepared to tell members of Congress on Tuesday that it expects to have more than 20 million doses ready by the end of March to protect against COVID-19,…


Johnson & Johnson: One-Shot COVID-19 Vaccine 66 Percent Effective in Global Trial

A clinical trial showed that Johnson & Johnson’s COVID-19 vaccine is 66 percent effective at preventing moderate to severe disease, the company said Friday. That level of protection came 28 days after vaccination, according to data from a global phase 3 trial. Onset of protection was observed as early as day 14. The level rose…


US Approval of AstraZeneca, Johnson & Johnson Vaccines Likely ‘Weeks Away’: Fauci

A COVID-19 vaccine developed by Johnson & Johnson, and another by AstraZeneca and Oxford University, are likely “weeks away” from being presented to U.S. regulators for approval, Dr. Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases, said Sunday. “We’re weeks away, not months away, for sure,” said Fauci, speaking on NBC’s “Meet…